University of Edinburgh
Graphene foam-based electrochemical biosensors for point-of-care molecular diagnostics in infection medicine
Abstract
dc:description.abstractEmerging infectious diseases and the growing burden of antimicrobial resistance (AMR) are major global health threats. These challenges demand rapid and easy-to-use molecular point-of-care tests for timely detection and surveillance. This thesis presents a label- and amplification-free electrochemical biosensor based on commercial graphene foam electrodes functionalised with peptide nucleic acid (PNA) probes and electrochemical impedance spectroscopy (EIS) as the sensing readout. Initial experiments evaluated graphene foam as an electrochemical sensing substrate. Its three-dimensional porous structure provided an electroactive surface area 113% larger than that of a non-foam graphene electrode. Graphene foam also showed a low and highly reproducible initial EIS baseline charge transfer resistance, providing a stable starting point for biosensing. A mechanistic study investigated nucleic acid adsorption on graphene foam using EIS as a time-resolved, label-free method. ssDNA adsorption depended on both sequence and strand length, while double-stranded DNA showed weaker adsorption than ssDNA. These findings support a hybridisation-induced duplex desorption process on graphene foam, help explain the electrochemical signal response after target binding, and indicate why pyrene-assisted anchoring is needed for stable probe immobilisation and a predictable response. The biosensor functionalisation strategy therefore used pyrene-modified PNA probes immobilised non-covalently through π-π stacking. The probe density was optimised through co-immobilisation with pyrene-butanol. This approach avoided on-surface coupling chemistry and provided a simpler, more controllable method for surface functionalisation. As a proof of concept, the biosensor detected the colistin resistance gene mcr-1 in a size-matched single-stranded DNA (ssDNA) target and directly in plasmids extracted from clinical isolates, achieving detection limits of 80 nM and 7.4 pM, respectively. Building on this immobilisation strategy, a heat-assisted protocol reduced probe immobilisation time from 12 h to 2 min while maintaining comparable probe loading and expanding the linear detection range. Retargeting the surface to detect a second AMR target sequence, blaNDM, demonstrated the platform’s adaptability. A storage study examined the stability of graphene foam electrodes as a practical requirement for deployment. Long-term EIS and CV monitoring showed that although freshly produced graphene foam electrodes had high initial reproducibility, their electrochemical behaviour shifted during storage. Headspace analysis identified volatile compounds from packaging materials and electrode components as candidate contributors to storage-related ageing. Overall, this thesis establishes the analytical feasibility of graphene foam-based biosensors for label- and amplification-free nucleic acid sensing and identifies the interfacial, material, and storage-related factors that should be considered during further development towards molecular point-of-care testing.
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Wang, Kayla Yinmiao
- Advisors dc:contributor.advisor
-
- Bachmann, Till
- Chen, Michael
- Dhaliwal, Kanwaldeep
Subjects
dc:subject × 7Rights
- Language dc:language.iso
- en
Identifiers
dc:identifier.*- Identifier URI
- https://doi.org/10.7488/era/7957